A Case of Relapsed Primary Central Nervous System Lymphoma Treated with CD19-directed Chimeric Antigen Receptor T Cell Therapy-Reference-Cited by-同舟云学术

A Case of Relapsed Primary Central Nervous System Lymphoma Treated with CD19-directed Chimeric Antigen Receptor T Cell Therapy

Published:2022-12-31 Issue:0 Volume:9 Page:275-280
ISSN:2188-4226
Container-title:NMC Case Report Journal
language:en
Short-container-title:

Author:

MIZUTA Ryo¹,OTANI Yoshihiro¹,FUJII Kentaro¹,UNEDA Atsuhito¹,ISHIDA Joji¹,TANAKA Takehiro²,IKEGAWA Shuntaro³,FUJII Nobuharu³,MAEDA Yoshinobu³,DATE Isao¹

Affiliation:

1. Department of Neurological Surgery, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences

2. Department of Pathology, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences

3. Department of Hematology and Oncology, Okayama University Faculty of Medicine, Dentistry and Pharmaceutical Sciences

Publisher

Japan Neurosurgical Society

Subject

Polymers and Plastics,General Environmental Science

Link

https://www.jstage.jst.go.jp/article/nmccrj/9/0/9_2022-0134/_pdf

Reference22 articles.

1. 1) Gregory G, Arumugaswamy A, Leung T, et al.: Rituximab is associated with improved survival for aggressive B cell CNS lymphoma. Neuro Oncol 15: 1068-1673, 2013

2. 2) Ferreri AJ: How I treat primary CNS lymphoma. Blood 118: 510-522, 2011

3. 3) Rubenstein J, Ferreri AJ, Pittaluga S: Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Leukemia & Lymphoma 49: 43-51, 2008

4. 4) Ichikawa T, Kurozumi K, Michiue H, et al.: Reduced neurotoxicity with combined treatment of high-dose methotrexate, cyclophosphamide, doxorubicin, vincristine and prednisolone (M-CHOP) and deferred radiotherapy for primary central nervous system lymphoma. Clin Neurol Neurosurg 127: 106-111, 2014

5. 5) Lee DW, Santomasso BD, Locke FL, et al.: ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells. Biol Blood Marrow Transplant 25: 625-638, 2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How can we improve the successful identification of patients suitable for CAR-T cell therapy?;Expert Review of Molecular Diagnostics;2024-09-11